FEROX STRATEGIES

Lobbying for ATRIUM THERAPEUTICS · Biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income · posted Apr 17, 2026

Lobbying activity 1

Health Issues

General issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.